Table 1 Patient characteristics
|  | Patients participating in pilot phase (N = 86) | Patients participating in evaluation (N = 71) | |
|---|---|---|---|
Age (in years) | (median, IQR) | 62.0 (14.5) | 61.0 (15) |
ALSFRS_R-score at the start of the pilot phase | (median, IQR) | 37 (12) | 37 (10) |
Gender | |||
 Male | (n, %) | 51 (59.3%) | 42 (59.2%) |
 Female | (n, %) | 35 (40.7%) | 29 (40.8%) |
Diagnosis | |||
 ALS | (n, %) | 65 (75.6%) | 53 (74.6%) |
 PMA | (n, %) | 14 (16.3%) | 11 (15.5%) |
 PLS | (n, %) | 7 (8.1%) | 7 (9.9%) |
Duration of the disease | (median, IQR) | 1 (2) | 1 (3) |